"Demyelinating Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Descriptor ID |
D003711
|
| MeSH Number(s) |
C10.314
|
| Concept/Terms |
Demyelinating Diseases- Demyelinating Diseases
- Demyelinating Disease
- Demyelinating Disorders
- Demyelinating Disorder
|
Below are MeSH descriptors whose meaning is more general than "Demyelinating Diseases".
Below are MeSH descriptors whose meaning is more specific than "Demyelinating Diseases".
This graph shows the total number of publications written about "Demyelinating Diseases" by people in this website by year, and whether "Demyelinating Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 6 | 1 | 7 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 2 | 0 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 6 | 0 | 6 |
| 2007 | 2 | 0 | 2 |
| 2008 | 0 | 3 | 3 |
| 2009 | 2 | 2 | 4 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 3 | 0 | 3 |
| 2021 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Demyelinating Diseases" by people in Profiles.
-
A recurrent missense variant in ITPR3 causes demyelinating Charcot-Marie-Tooth with variable severity. Brain. 2025 Jan 07; 148(1):227-237.
-
Remyelination protects neurons from DLK-mediated neurodegeneration. Nat Commun. 2024 Oct 23; 15(1):9148.
-
TMEM106B regulates microglial proliferation and survival in response to demyelination. Sci Adv. 2023 05 05; 9(18):eadd2676.
-
Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. Mult Scler Relat Disord. 2023 Mar; 71:104573.
-
Activation of mTORC1 and c-Jun by Prohibitin1 loss in Schwann cells may link mitochondrial dysfunction to demyelination. Elife. 2021 09 14; 10.
-
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020 07 14; 95(2):e111-e120.
-
Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol. 2020 07; 88(1):42-55.
-
In vivo evolution of biopsy-proven inflammatory demyelination quantified by R2t* mapping. Ann Clin Transl Neurol. 2020 06; 7(6):1055-1060.
-
Mature myelin maintenance requires Qki to coactivate PPAR?-RXRa-mediated lipid metabolism. J Clin Invest. 2020 05 01; 130(5):2220-2236.
-
Phenotypic and Imaging Spectrum Associated With WDR45. Pediatr Neurol. 2020 08; 109:56-62.